Search Results - "Bhamidipati, Ravi Kanth"
-
1
A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
Published in Scientific reports (26-02-2018)“…Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from the co-factor S-adenosyl-L-methionine (SAM)…”
Get full text
Journal Article -
2
Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase
Published in Bioorganic & medicinal chemistry letters (01-03-2018)“…Compound 12 Human/mouse NNMT enzymatic inhibition (IC50): 0.58/4.5 µM. Inhibition of MNA in U2OS/3T3L1 cell based assay: 0.3/2.1 µM. Human/mouse metabolic…”
Get full text
Journal Article -
3
Validated LC–MS-MS Method for Determination of SF0034 in Mice Plasma: Application to a Pharmacokinetic Study in Mice
Published in Journal of chromatographic science (01-08-2017)“…Abstract A rapid and sensitive assay method has been developed and validated using liquid chromatography coupled to tandem mass spectrometry with electrospray…”
Get full text
Journal Article -
4
Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles - Case Studies of ABT-279, ABT-341, Alogliptin, Carmegliptin, Sitagliptin and Vildagliptin
Published in Journal of pharmacy & pharmaceutical sciences (01-01-2015)“…The purpose of this exercise was to explore the utility of allometric scaling approach for the prediction of intravenous and oral pharmacokinetics of six…”
Get full text
Journal Article -
5
Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as linear, log-linear and power models
Published in Xenobiotica (01-02-2018)“…1. Dalbavancin, a lipoglycopeptide, is approved for treating gram-positive bacterial infections. Area under plasma concentration versus time curve (AUC inf )…”
Get full text
Journal Article -
6
LC–MS/MS determination of tideglusib, a novel GSK-3β inhibitor in mice plasma and its application to a pharmacokinetic study in mice
Published in Journal of pharmaceutical and biomedical analysis (30-01-2018)“…[Display omitted] •First bioanalytical method being reported for quantification of tideglusib in mice plasma on LC–MS/MS.•Simple sample processing method and…”
Get full text
Journal Article -
7
Preclinical assessment of ulixertinib, a novel ERK1/2 inhibitor
Published in ADMET & DMPK (01-12-2017)“…Ulixertinib (BVD-523) is a novel and selective reversible inhibitor of ERK1/ERK2. In xenograft studies it inhibited tumor growth in BRAF-mutant melanoma and…”
Get full text
Journal Article Paper -
8
High‐throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry
Published in Biomedical chromatography (01-05-2020)“…Ceramides are known to be involved in various biological processes with their physiological levels elevated in various disease conditions such as diabetes,…”
Get full text
Journal Article -
9
Interspecies scaling of urinary excretory amounts of nine drugs belonging to different therapeutic areas with diverse chemical structures - accurate prediction of the human urinary excretory amounts
Published in Xenobiotica (01-02-2017)“…1. The human urinary excretory amounts of total drug (parent + metabolites) were predicted for nine drugs with diverse chemical structures using simple…”
Get full text
Journal Article -
10
Cover Image
Published in Biomedical chromatography (01-05-2020)“…The cover image is based on the Short Communication High throughput screening assay for quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0,…”
Get full text
Journal Article -
11
-
12
Prediction of Human Pharmacokinetics of Fomepizole from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles
Published in AAPS PharmSciTech (01-08-2019)“…Fomepizole is used as an antidote to treat methanol poisoning due to its selectivity towards alcohol dehydrogenase. In the present study, the goal is to…”
Get full text
Journal Article -
13
Validation of an LC–MS/MS Method for Simultaneous Detection of Five Selective KCNQ Channel Openers: ICA-27243, ML-213, PF-05020182, SF-0034 and Flupirtine in Mice Plasma and its Application to a Pharmacokinetic Study in Mice
Published in Chromatographia (01-03-2018)“…A sensitive and rapid LC–MS/MS method was developed and validated for the simultaneous quantitation of five selective KCNQ channel openers, namely ICA-27243,…”
Get full text
Journal Article -
14
Sensitive LC-MS/MS Method for the Simultaneous Determination of Bendamustine and its Active Metabolite, γ-Hydroxybendamustine in Small Volume Mice and Dog Plasma and its Application to a Pharmacokinetic Study in Mice and Dogs
Published in Drug research (01-09-2017)“…A highly sensitive, specific and rapid LC-ESI-MS/MS method has been developed and validated for the simultaneous quantification of bendamustine (BM) and…”
Get more information
Journal Article -
15
Development and validation of an RP-HPLC method for the quantitation of odanacatib in rat and human plasma and its application to a pharmacokinetic study
Published in Biomedical chromatography (01-11-2015)“…A simple, specific, sensitive and reproducible high‐performance liquid chromatography (HPLC) assay method has been developed and validated for the estimation…”
Get full text
Journal Article -
16
Prediction of Human Pharmacokinetics of Bendamustine from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles
Published in Drug research (01-01-2019)“…Bendamustine, an alkylating anticancer agent, is used to treat chronic lymphocytic leukemia by intravenous infusion alone or in combination. The work aimed to…”
Get more information
Journal Article -
17
Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics
Published in European journal of drug metabolism and pharmacokinetics (01-08-2018)“…Background and Objectives Ulixertinib (BVD-523) is a novel and selective reversible inhibitor of ERK1/ERK2. The primary objectives of the study were to…”
Get full text
Journal Article -
18
Validation of an LC–MS/MS method for simultaneous detection of four HDAC inhibitors – belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic study
Published in Biomedical chromatography (01-07-2017)“…A sensitive and rapid LC–MS/MS method was developed and validated for the simultaneous quantitation of four HDAC inhibitors, namely belinostat (BST),…”
Get full text
Journal Article -
19
LC‐ESI‐MS/MS determination of 4‐methylpyrazole in dog plasma and its application to a pharmacokinetic study in dogs
Published in Biomedical chromatography (01-02-2018)“…A simple, specific, sensitive and rapid LC‐ESI‐MS/MS method has been developed and validated for the quantification of 4‐methylpyrazole in dog plasma using…”
Get full text
Journal Article -
20
Sensitive method for the determination of rocilinostat in small volume mouse plasma by LC-MS/MS and its application to a pharmacokinetic study in mice
Published in Biomedical chromatography (01-07-2016)“…A highly sensitive, specific and rapid LC‐ESI‐MS/MS method has been developed and validated for the quantification of rocilinostat in small volume mouse plasma…”
Get full text
Journal Article